Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Cytotoxicity of acetylcholinesterase reactivators evaluated in vitro and its relation to their structure

L. Muckova, J. Pejchal, P. Jost, N. Vanova, D. Herman, D. Jun,

. 2019 ; 42 (3) : 252-256. [pub] 20180209

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19028584

The development of acetylcholinesterase reactivators, i.e., antidotes against organophosphorus poisoning, is an important goal of defense research. The aim of this study was to compare cytotoxicity and chemical structure of five currently available oximes (pralidoxime, trimedoxime, obidoxime, methoxime, and asoxime) together with four perspective oximes from K-series (K027, K074, K075, and K203). The cytotoxicity of tested substances was measured using two methods - colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide assay and impedance based real-time cytotoxicity assay - in three different cell lines (HepG2, ACHN, and NHLF). Toxicity was subsequently expressed as toxicological index IC50. The tested compounds showed different cytotoxicity ranging from 0.92 to 40.06 mM. In HepG2 cells, K027 was the least and asoxime was the most toxic reactivator. In ACHN and NHLF cell lines, trimedoxime was the compound with the lowest adverse effects, whereas the highest toxicity was found in methoxime-treated cells. The results show that at least five structural features affect the reactivators' toxicity such as the number of oxime groups in the molecule, their position on pyridinium ring, the length of carbon linker, and the oxygen substitution or insertion of the double bond into the connection chain. Newly synthetized oximes with IC50 ≥ 1 mM evaluated in this three cell lines model might appear suitable for further testing.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19028584
003      
CZ-PrNML
005      
20190823092553.0
007      
ta
008      
190813s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1080/01480545.2018.1432641 $2 doi
035    __
$a (PubMed)29421945
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Muckova, Lubica $u a Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences , University of Defence , Trebesska, Hradec Kralove , Czech Republic.
245    10
$a Cytotoxicity of acetylcholinesterase reactivators evaluated in vitro and its relation to their structure / $c L. Muckova, J. Pejchal, P. Jost, N. Vanova, D. Herman, D. Jun,
520    9_
$a The development of acetylcholinesterase reactivators, i.e., antidotes against organophosphorus poisoning, is an important goal of defense research. The aim of this study was to compare cytotoxicity and chemical structure of five currently available oximes (pralidoxime, trimedoxime, obidoxime, methoxime, and asoxime) together with four perspective oximes from K-series (K027, K074, K075, and K203). The cytotoxicity of tested substances was measured using two methods - colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide assay and impedance based real-time cytotoxicity assay - in three different cell lines (HepG2, ACHN, and NHLF). Toxicity was subsequently expressed as toxicological index IC50. The tested compounds showed different cytotoxicity ranging from 0.92 to 40.06 mM. In HepG2 cells, K027 was the least and asoxime was the most toxic reactivator. In ACHN and NHLF cell lines, trimedoxime was the compound with the lowest adverse effects, whereas the highest toxicity was found in methoxime-treated cells. The results show that at least five structural features affect the reactivators' toxicity such as the number of oxime groups in the molecule, their position on pyridinium ring, the length of carbon linker, and the oxygen substitution or insertion of the double bond into the connection chain. Newly synthetized oximes with IC50 ≥ 1 mM evaluated in this three cell lines model might appear suitable for further testing.
650    _2
$a alternativy testů na zvířatech $7 D000826
650    _2
$a viabilita buněk $x účinky léků $7 D002470
650    _2
$a reaktivátory cholinesterasy $x chemie $x toxicita $7 D002801
650    _2
$a preklinické hodnocení léčiv $7 D004353
650    _2
$a fibroblasty $x účinky léků $7 D005347
650    _2
$a buňky Hep G2 $7 D056945
650    _2
$a lidé $7 D006801
650    _2
$a inhibiční koncentrace 50 $7 D020128
650    _2
$a LD50 $7 D007928
650    _2
$a molekulární struktura $7 D015394
650    _2
$a oximy $x chemie $x toxicita $7 D010091
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
655    _2
$a časopisecké články $7 D016428
700    1_
$a Pejchal, Jaroslav $u a Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences , University of Defence , Trebesska, Hradec Kralove , Czech Republic.
700    1_
$a Jost, Petr $u a Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences , University of Defence , Trebesska, Hradec Kralove , Czech Republic.
700    1_
$a Vanova, Nela $u a Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences , University of Defence , Trebesska, Hradec Kralove , Czech Republic.
700    1_
$a Herman, David $u a Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences , University of Defence , Trebesska, Hradec Kralove , Czech Republic.
700    1_
$a Jun, Daniel $u a Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences , University of Defence , Trebesska, Hradec Kralove , Czech Republic. b Biomedical Research Centre, University Hospital Hradec Kralove , Sokolska, Hradec Kralove , Czech Republic.
773    0_
$w MED00001436 $t Drug and chemical toxicology $x 1525-6014 $g Roč. 42, č. 3 (2019), s. 252-256
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29421945 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190823092808 $b ABA008
999    __
$a ok $b bmc $g 1433733 $s 1067044
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 42 $c 3 $d 252-256 $e 20180209 $i 1525-6014 $m Drug and chemical toxicology $n Drug Chem Toxicol $x MED00001436
LZP    __
$a Pubmed-20190813

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...